Oct. 22 at 6:03 PM
Lakeview Investment Group, which owns nearly 5% of Quipt Home Medical Corp, criticized the company’s board for allegedly ignoring a credible takeover offer and called for a transparent strategic review.
In a statement released Wednesday, Lakeview accused Quipt’s board of failing shareholders by not properly engaging with Forager Capital Management, which has made multiple acquisition proposals, including one at
$3.10 per share.
The investment firm pointed to Quipt’s weak stock performance, noting negative returns over one-, three-, and five-year periods, compared with a 16.4% gain for the S&P 500 over the past year.
Lakeview also condemned the board’s March 2025 decision to award itself restricted shares and options representing about 7% of the company’s stock — shortly after receiving acquisition proposals from Forager.
$QIPT